Article
Metabolic armouring of CAR and TCR T cells
2024-03-28
Abstract excerpt
<title>Abstract</title> <p>Cancer immune therapy with engineered immune cells is standard of care in certain hematologic malignancies. However, solid tumor outcomes in clinical trials are lagging significantly behind. Engineered T cells face a myriad of challenges within the tumor microenvironment, one of which is competition for metabolites and a carbon source for adenosine triphosphate generation. Glucose is th...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3c800552-6dd8-511a-8653-88dec9bc7683
- DOI
- 10.21203/rs.3.rs-4020589/v1
